4/17
07:25 am
athe
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
High
Report
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
4/16
07:25 am
athe
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
Medium
Report
Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting
4/15
07:25 am
athe
Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy
Medium
Report
Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy
3/30
08:05 am
athe
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program [Yahoo! Finance]
High
Report
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program [Yahoo! Finance]
3/30
07:25 am
athe
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
Low
Report
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
3/9
07:25 am
athe
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
Neutral
Report
Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit
3/4
07:51 am
athe
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor [Yahoo! Finance]
Neutral
Report
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor [Yahoo! Finance]
3/4
07:25 am
athe
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor
Neutral
Report
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor
4/17
06:04 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
High
Report
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
4/16
06:06 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
Medium
Report
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
4/15
07:50 pm
athe
Form 3 ALTERITY THERAPEUTICS For: Apr 15 Filed by: Stamler David Allen
Medium
Report
Form 3 ALTERITY THERAPEUTICS For: Apr 15 Filed by: Stamler David Allen
4/15
06:08 am
athe
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
Medium
Report
Form 6-K ALTERITY THERAPEUTICS For: Apr 30
4/10
08:22 am
athe
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Gozlan Lawrence Bernard
Medium
Report
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Gozlan Lawrence Bernard
4/10
08:17 am
athe
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Babarczy Julian Michael
Medium
Report
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Babarczy Julian Michael
4/10
07:57 am
athe
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Marks Peter Ashley
Medium
Report
Form 3 ALTERITY THERAPEUTICS For: Apr 10 Filed by: Marks Peter Ashley
4/9
09:58 pm
athe
Form 3 ALTERITY THERAPEUTICS For: Apr 09 Filed by: Macnish Niven Abby Sarah
Medium
Report
Form 3 ALTERITY THERAPEUTICS For: Apr 09 Filed by: Macnish Niven Abby Sarah
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register